AnalystsSean McCutcheonSean McCutcheon's Stock Forecasts
AnalystsSean McCutcheon
Sectors:
Industries:
Analyst Ranking
Top 47%
#2433 out of 5153 analysts
Average Return
+1.36%
Win Rate
45%5 out of 11
Risk vs Reward
Poor
Good
Sean McCutcheon's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Compass Therapeutics IncCMPX | +96.90% | $2.58 | $5.08 | 2025-06-30 - 2025-12-15 | Buy |
Revolution Medicines IncRVMD | +69.71% | $46.55 | $79.00 | 2025-09-11 - 2025-12-15 | Strong Buy |
Revolution Medicines IncRVMD | +46.03% | $54.10 | $79.00 | 2025-10-16 - 2025-12-15 | Strong Buy |
Vir Biotechnology IncVIR | +18.94% | $5.65 | $6.72 | 2025-07-10 - 2025-12-15 | Buy |
Black Diamond Therapeutics IncBDTX | +6.85% | $2.48 | $2.65 | 2025-06-30 - 2025-12-15 | Buy |
Sean McCutcheon Analyst Color
Get additional color on Sean McCutcheon's coverage of popular stocks
Sean McCutcheon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revolution Medicines IncRVMD | 2 | Strong Buy | $76.00 | -3.80% | Maintains | 2 months ago |
Vir Biotechnology IncVIR | 1 | Buy | $12.00 | +78.57% | Initiates Coverage On | 5 months ago |
Janux Therapeutics IncJANX | 1 | Buy | $65.00 | +329.89% | Initiates Coverage On | 5 months ago |
Compass Therapeutics IncCMPX | 1 | Buy | $9.00 | +77.17% | Reinstates | 6 months ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | $11.00 | +315.09% | Reinstates | 6 months ago |
Engene Holdings IncENGN | 1 | Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Xencor IncXNCR | 1 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Cytokinetics IncCYTK | 2 | Buy | $70.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 1 | Buy | $86.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.